glp-1 and kidney Glucagon-like Peptide-1 Receptor Agonists Diabetic Disease: From Bench to Bed-Side GLP-1 Agonism for Kidney Transplant

They are generally safe for long-term use and work effectively by being added to the bloodstream

Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis

Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons

This effect is dose-dependent: higher doses typically produce stronger motility slowing and increased constipation risk

Prevention is straightforward but requires discipline

Menopause can bring more than just hot flashes and mood swings, it can also usher in an expanding waistline that defies diet and exercise